Dr. Tobias Kruse shares how his company is filling a gap for digitalization in clinical trial patient recruitment and why patients and sponsors are benefitting.

Eric Doherty is President of PERSOWN, the company striving to make a life-saving impact by delivering accurate, rapid and affordable diagnostics to the point of care, anywhere in the world.

SAS’ Antonio DeCastro joins Alex on the podcast to share his perspective on patient-centricity and the role of consumerism in driving innovation and better outcomes in health care and life sciences.

What has disruption taught us about global supply chains? Dr. Robert Handfield shares his vision on what agile and resilient supply chain models look like in the future. He is the Bank of America University Distinguished Professor of Operations and Supply Chain Management at North Carolina State University, as well as Founder and Executive Director of The Supply Chain Resource Cooperative. On this episode, Handfield joins host Alex Maiersperger to talk about the impact of the pandemic on...

For Felipe Sotelo, it’s all about priorities. That’s why Dad & Husband are the titles on his LinkedIn profile. It’s also why he now believes demand forecast agility is more important than accuracy in the post-pandemic world of supply chain disruptions. On this episode of The Health Pulse, positive thinker, business reinvention leader and writer Sotelo joins host Alex Maiersperger to share his insights as a supply chain leader for organizations including Johnson & Johnson, Teva...

Is it too much to expect health care to deliver delightful experiences? Dr. Koen Kas doesn’t think so, and his vision includes digital twins, personal data stores and preventive medicine. He is a health care visionary, digital health and biomarker expert, health-tech entrepreneur, Professor of Molecular Oncology and Digital Health at the University of Ghent, international keynote speaker and author of Sick No More and Your Guide to Delight. Host Alex Maiersperger and Kas talk about the...

Dr. Sean Khozin is on a mission to break down silos and improve access to quality cancer care for all. Khozin is a board-certified oncologist, physician scientist, data scientist and the CEO of ASCO’s CancerLinQ, a nonprofit health technology company focused on improving health outcomes for all patients with cancer. On this episode of The Health Pulse, Khozin joins host Alex Maiersperger to discuss how his organization is democratizing access to the best cancer care by bringing real-world...

Join us in our conversation with the CEO of Transgrid, Brett Redman, as we discuss the state of the overall electricity industry landscape in Australia, his perspectives on innovation in the industry, and importance of transmission in helping achieve sustainability targets for a cleaner and greener world order.

In this episode, Greg speaks with Professor Patricia Maguire, Biomedical Scientist and Director of University College Dublin’s Institute for Discovery. Maguire’s research focuses on platelets, an interest that began 25 years ago when her father suffered his first heart attack and she recognized the need for better diagnostics in the clinic.

On this episode, Greg catches up colleague Reggie Townsend, director of the Data Ethics Practice at SAS. Recognizing the increasing market need around data ethics, SAS formed the practice to establish principles and processes for governing Artificial Intelligence (AI). The practice applies a human-centric approach to upholding principles such as transparency, accountability and inclusivity in data science. Townsend challenges his team to start by considering the impact of technology on the...

On this episode, Greg is joined by Dr. Melissa Strong, founder and lead data scientist for IndiOmics. Her background is in molecular biology and epigenetics, or how our environment can affect our gene expression. IndiOmics’ mission is to educate the public about common chemicals that can affect us on a cellular level and what we can do to prevent exposure. Much of its work focuses on endocrine-disrupting chemicals (EDCs). By completing IndiOmics’ home-based kit, participants get a...

On this episode, Greg Horne talks with Dr. Robert Winn, Director of VCU Massey Cancer Center. In his role and his life, Dr. Winn focuses on two goals – eradicating cancer and removing disparities in access to quality health care. Dr. Winn is a national thought leader on using social determinant of health data to inform cancer epidemiology and increase access to quality treatment for all it. It’s a simple credo that isn't easy to put into action due to historical and structural barriers. Trust...

On this episode, Greg Horne interviews Craig Lipset, advisor, advocate and educator in the area of decentralized clinical trials and the former head of clinical innovation at Pfizer. During his time at Pfizer, Craig helped design and lead the first fully remote, decentralized trial. Surprisingly, that was more than a decade ago. Craig explains that the methods, investment and regulatory readiness around decentralized clinical trials has long existed in the industry. The pandemic-related...

On this episode host Greg Horne interviews David Rhew, M.D., Global Chief Medical Officer & VP of Healthcare for Microsoft, on the role of technology in health care. Dr. Rhew observed early in his career that evidence-based practices often lead to better health outcomes, but they aren’t adhered to consistently. From there he set out on a digital transformation journey that quickly brought him into health tech and eventually Microsoft. Dr. Rhew and Greg discuss the role of technology in...

Jennifer Byrne, CEO of contract research organization Javara Research, has a lifelong passion for serving patient populations through clinical research. On this episode, Jennifer shares with Greg the concept of learning health systems that improve health care through research. Javara brings a lot of the traditional advantages that a CRO brings to pharma to health care systems through an integrated research organization approach. The organization’s strategic vision and partnerships are...

On this episode, Greg is joined by Grainne Lynch, Senior Manager and Traceability Lead for Accenture. Grainne, an Irish native, helps pharmaceutical companies be compliant with supply chain legislation. She explains to Greg that the pharmaceutical industry is on the forefront of a consumer-led trend demanding the ability to track and trace products end-to-end throughout the supply chain. Now more than ever, consumers want to know a product’s entire history—where it came from, how materials...

Jessica DaMassa is the Executive Producer and Host of video series, What’s the Future, Health?, where she interviews key stakeholders in health tech to uncover unique perspectives on where the industry is headed. On this episode of The Health Pulse, Jessica briefly switches from her usual role as interviewer to guest to share her observations on the trends to watch in health care. The health tech space has seen an unprecedented influx of funding since the early months of the pandemic in 2020....

Caitlin Donovan is the Global Head of Uber Health. In this role, she’s responsible for figuring out how to fix logistical issues in health care. Coming from a variety of health care executive roles before joining Uber Health, Caitlin observed that all too often what goes wrong in health care isn’t clinical—it’s what happens when patients aren’t in front of their provider. Maybe they don’t have transportation to an appointment, their prescription didn’t arrive or they don’t have access to the...

Dr. Dawnté Early (she/her) is the Chief of Research and Evaluation for the Mental Health Services Oversight and Accountability Commission in California. Dr. Early supports the Commission’s mission is to transform the mental health system so that everyone who needs care in California receives high-quality and culturally competent care. A big part of her job is bringing together mental health data at the individual level with data from different agencies, including criminal justice, education,...

On this episode, Greg is joined by Herman De Prins, Global CIO of biopharma company UCB. Herman describes UCB’s journey into artificial intelligence (AI), which began with projects aimed at treatments for epilepsy. Herman also shares how UCB promoted data literacy and AI among its staff of more than 8,000 people worldwide, and how the company prioritizes the many projects brought forward by its team of AI enthusiasts. Herman emphasized that there is value in AI across the pharmaceutical value...

Peter Muhoro has a front row seat for the ongoing energy transition, so the VP of strategy and technology at Rappahannock Electric Cooperative is the perfect guest to talk with host Sal Gill about what it will require for utilities to start building tomorrow today.

On this episode, Greg talks with Dana Bernson, epidemiologist and Director of Special Analytic Projects at the Massachusetts Department of Public Health, about her work to use data and analytics to guide public health planning and crisis response. Dana shares insights from the department’s initial effort to link data sources across state government to get more contextual information to help address the opioid epidemic. Not surprisingly, one data set often gives us a piece of the puzzle, but...

Ahad Esmaeilian is helping drive us toward the electricity system of the future. The director of business development for Avangrid, Ahad has earned a Ph.D. from Texas A&M and holds master’s degrees from universities in both the U.S. and his home country of Iran. And while Ahad’s daily focus is to work across the industry to advance clean energy through the interconnection of wind, solar and other utility-scale renewable energy resources, his academic and professional careers have largely...

On this episode, Greg chats with SAS EMEA life sciences sales director Jonathan Riches about digital transformation in pharma. Jonathan argues that while buzzword technology like artificial intelligence (AI) and machine learning get a lot of attention, it’s really culture that determines an organization’s success with digital transformation. Why? The life sciences industry is highly regulated by necessity, and many pharmaceutical companies have been around for one hundred or more years. So,...

Dawn James is a violinist, a geoscientist, a mom and a technology solutions professional. She could even help you understand how fluvial sedimentology works! But those descriptors only scratch the surface of the experience and expertise Dawn brings to her role as the U.S. director of sustainability and environmental services at Microsoft. On this episode of Electrifying AI, Dawn joins host Sal Gill to examine how analytics, artificial intelligence and cloud technologies are playing a role in...